Downtrend on the daily chart: below its 50-day average · SuperTrend down since Sep 28 · below the Ichimoku cloud · RSI 40 · MACD below its signal
None of the 29 investors followed here reported a position in APTX.TO in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a APTX.TO trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 17, 2026 | Oberman (Allan)Director of Issuer | Exercise of rights at price 0.01 per share. | 532.1K | $3.72K |
| Sep 17, 2026 | Oberman (Allan)Director of Issuer | Disposition under a prospectus at price 24.31 per share. | 532.1K | $12.93M |
| Sep 17, 2026 | Sk Artemis Holdings Ii Llc10% Security Holder of Issuer | Disposition under a prospectus at price 24.31 per share. | 19.25M | $467.98M |
| Jun 8, 2026 | Alon (Ariel)Senior Officer of Issuer | — | 0 | — |
| Jun 8, 2026 | Ares (Martin)Senior Officer of Issuer | — | 0 | — |
| Jun 8, 2026 | Baeder (Christine)Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) | — | 0 | — |
| Jun 8, 2026 | Davis (Sarah Ruth)Director of Issuer | — | 0 | — |
| Jun 8, 2026 | Firestone (Theresa)Director of Issuer | — | 0 | — |
| Jun 8, 2026 | Fishman (Barry)Senior Officer of Issuer | — | 0 | — |
| Jun 8, 2026 | Krinsky (Itzhak)Director of Issuer | — | 0 | — |
| Jun 8, 2026 | Krishnan (Kiran)Senior Officer of Issuer | — | 0 | — |
| Jun 8, 2026 | Mcclelland (Brian George)Senior Officer of Issuer | — | 0 | — |
| Jun 8, 2026 | Mcgavock (Racquel Tan)Senior Officer of Issuer | — | 0 | — |
| Jun 8, 2026 | Oberman (Allan)Director of Issuer | — | 0 | — |
| Jun 8, 2026 | Oberman (Allan)Director of Issuer | — | 0 | — |
| Jun 8, 2026 | Sanghvi (Pradeepkumar)Senior Officer of Issuer | — | 0 | — |
| Jun 8, 2026 | Sk Artemis Holdings Ii Llc10% Security Holder of Issuer | — | 0 | — |
| Jun 8, 2026 | Tallarico (Francesco)Senior Officer of Issuer | — | 0 | — |
| Jun 8, 2026 | Vassilieva (Carina)Senior Officer of Issuer | — | 0 | — |
| Jun 8, 2026 | Watson (Jeff)Director of Issuer | — | 0 | — |
Apotex Health Corp. operates as a pharmaceutical manufacturing company in Canada, the United States, Mexico, and India. The company develops, manufactures, and distributes a broad portfolio of prescription and generic pharmaceuticals, oncology biosimilar pharmaceuticals, branded specialty pharmaceuticals, and branded consumer health and wellness products. It operates through three business lines including conventional generic pharmaceuticals; specialty generic pharmaceuticals; and brands & biosimilars. The company has a a strategic partnership with Halo Pharmaceutical, Inc. The company was formerly known as Artemis Parent, Inc. and changed its name to Apotex Health Corp. in May 2026. Apotex Health Corp. was founded in 1974 and is headquartered in Toronto, Canada. Apotex Health Corp. operates as a subsidiary of SK Artemis Holdings, II, LLC
Buy / hold / sell counts
No recent headlines.